Owner
Birgit Funke Consulting LLC
Newton, Massachusetts, United States
Dr. Funke received her Ph.D. from the University of Würzburg, Germany and trained as a postdoctoral fellow at the Albert Einstein College of Medicine where she identified the gene for 22q11 deletion syndrome. She is Board certified in Clinical Molecular Genetics, served as Associate Professor of Pathology at Harvard Medical School where she was among the first worldwide to implement clinical NGS in 2011 at the Laboratory for Molecular Medicine in Cambridge. From 2017 to 2023, Dr. Funke has served in several leadership roles in commercial genetic testing laboratories where she focused on implementing and scaling testing for hereditary cancer, cardiovascular disease as well as proactive genomic applications. She has authored numerous guidelines on cutting edge clinical genetic testing to advance laboratory practice.
Academically, Dr. Funke is known for her work on the genetic landscape of inherited cardiomyopathies, leading international efforts to develop professional guidelines for clinical genomic knowledge curation, as well as development of cutting edge clinical genomic tests. Her long-term goal is to help increase the use of genomic testing in clinical care, especially for disease prevention.
Disclosure information not submitted.
Saturday, November 18, 2023
10:15 AM - 10:45 AM MST
What's in a Name? HGVS and Nomenclature for Genomics - Past & Future (Q & A)
Saturday, November 18, 2023
11:15 AM - 11:45 AM MST